Jeremy Abramson, MD, MD

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

• Post-transplant lymphoproliferative disease→
• Nodal T-follicular helper cell lymphoma, follicular type→
• Angioimmunoblastic T-cell lymphoma→
• Indolent B-cell non-Hodgkin lymphoma→
• Classic Hodgkin lymphoma→
• Anaplastic large cell lymphoma→

Clinical trials (5)

• NCT00644189
• NCT00722865
• NCT00895661
• NCT02142530
• NCT01058239

Verify independently

• ClinicalTrials.gov PI search for Jeremy Abramson, MD
• NPPES NPI registry entry

Other specialists for Post-transplant lymphoproliferative disease

Peers ranked by clinical-trial PI role, publications, and verification quality.

• Birte Wistinghausen, M.D
  Children's Oncology Group
  NY
• Cyrille TOUZEAU, Prof
  CHU Nantes France
• Aurore PERROT, Prof
  IUCT Toulouse France
• Kurt Gunter, MD, M.D
  Inozyme Pharma, Inc.
  MA
• David Maloney
  Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
• Corey Cutler, MD, MPH, F.N.P
  Dana-Farber Cancer Institute
  UT
• Chanaz LOUNI
  The Institute for Functional Medicine
• Leona Holmberg
  Fred Hutch/University of Washington Cancer Consortium
  WA

See all specialists for Post-transplant lymphoproliferative disease →